https://www.selleckchem.com/products/jh-re-06.html
sis was not effective to distinguish low to high risk patients in the studied population. Further studies are needed to validate its use in clinical practice in Brazil. Intravenous (IV) use of proton pump inhibitors (PPIs) is advised only in cases of suspected upper gastrointestinal bleeding (UGI or impossibility of receiving oral medication, although there has been a persistent practice of their inappropriate use in health institutions. The purpose of our study was to measure the inappropriate use of IV PPIs in a high complexity hos
Respect!
Kommentar
Delen
